Recently, Sparcl1 was reported to be upregulated in liver-specific Apobec1 complementation factor transgenic mice, which is charactered with a phenotype with spontaneous steatosis, fibrosis, and hepatocellular cancer (18). Here, SPARCL1 is linked to hepatocellular carcinoma.